MedPath
TGA Approval

IMBRUVICA ibrutinib 140 mg capsule bottle (228499)

228499

IMBRUVICA ibrutinib 140 mg capsule bottle

Janssen-Cilag Pty Ltd

April 20, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/9a3567254784aeaafba3fbf97530e391.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5352b9b8d83317106001f4cb426bab43.pdf

Active Ingredients

ibrutinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IMBRUVICA ibrutinib 140 mg capsule bottle (228499) - TGA 批准文号 | MedPath